Valentis (Pharmaceuticals) Overview
- Year Founded
-
1992
- Status
-
Acquired/Merged
- Latest Deal Type
-
M&A
- Investors
-
1
Valentis (Pharmaceuticals) General Information
Description
Developer of technologies for medicinal purpose. The company's technologies include multiple gene delivery and gene expression systems and PEGylation, which are designed to improve the safety, efficacy and dosing characteristics of genes, proteins, peptides, peptidomimetics, antibodies and viruses.
Contact Information
Website
www.valentis.comCorporate Office
- 533 Airport Boulevard
- Suite 400
- Burlingame, CA 94010
- United States
Corporate Office
- 533 Airport Boulevard
- Suite 400
- Burlingame, CA 94010
- United States
Valentis (Pharmaceuticals) Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 10. Merger/Acquisition | 16-Jul-2007 | Completed | Generating Revenue | |||
| 9. PIPE | 02-Jun-2006 | Completed | Generating Revenue | |||
| 8. PIPE | 28-Jun-2005 | Completed | Generating Revenue | |||
| 7. PIPE | 20-Aug-2004 | Completed | Generating Revenue | |||
| 6. PIPE | 10-Jun-2004 | Completed | Generating Revenue | |||
| 5. PIPE | 30-Jan-2004 | Completed | Generating Revenue | |||
| 4. PIPE | 31-Dec-2003 | Completed | Generating Revenue | |||
| 3. PIPE | 18-Sep-2003 | Completed | Generating Revenue | |||
| 2. PIPE | 14-Apr-2000 | $19.2M | $19.2M | Completed | Generating Revenue | |
| 1. Early Stage VC | 30-Sep-1996 | Completed | Generating Revenue |
Valentis (Pharmaceuticals) Former Investors (11)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| BCM Ventures | Venture Capital | Minority | ||
| BIT (AXA Framlington Investment Managers) | Mutual Fund | Minority | ||
| BSI-AG | Other | Minority | ||
| Banca Investis | Investment Bank | Minority | ||
| Compania Financiera | Lender/Debt Provider | Minority |
Valentis (Pharmaceuticals) Acquisitions (1)
Valentis (Pharmaceuticals)’s most recent deal was a Reverse Merger with Vaneltix Pharma. The deal was made on 16-Jul-2007.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Vaneltix Pharma | 16-Jul-2007 | Reverse Merger | Drug Discovery |
Valentis (Pharmaceuticals) FAQs
-
When was Valentis (Pharmaceuticals) founded?
Valentis (Pharmaceuticals) was founded in 1992.
-
Where is Valentis (Pharmaceuticals) headquartered?
Valentis (Pharmaceuticals) is headquartered in Burlingame, CA.
-
What industry is Valentis (Pharmaceuticals) in?
Valentis (Pharmaceuticals)’s primary industry is Drug Discovery.
-
Is Valentis (Pharmaceuticals) a private or public company?
Valentis (Pharmaceuticals) is a Private company.
-
What is Valentis (Pharmaceuticals)’s current revenue?
The current revenue for Valentis (Pharmaceuticals) is .
-
How much funding has Valentis (Pharmaceuticals) raised over time?
Valentis (Pharmaceuticals) has raised $67.9M.
-
Who are Valentis (Pharmaceuticals)’s investors?
BCM Ventures, BIT (AXA Framlington Investment Managers), BSI-AG, Banca Investis, and Compania Financiera are 5 of 11 investors who have invested in Valentis (Pharmaceuticals).
-
When was Valentis (Pharmaceuticals) acquired?
Valentis (Pharmaceuticals) was acquired on 16-Jul-2007.
-
Who acquired Valentis (Pharmaceuticals)?
Valentis (Pharmaceuticals) was acquired by Vaneltix Pharma.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process